Adverse events (
confusion, diarrhea, fatigue, toxicity, constipation, dizziness, headache, Toxicity, Cancer
ADVERSE EVENT, CANCER
Participants were evaluated for toxicity with the National Cancer Institute Common Toxicity Criteria for Adverse Events (NCI CTCAE v 5) weekly during the 4‐week titration and every 2–3 weeks thereafter, coinciding with chemotherapy infusion. Though all patient‐reported symptoms were recorded, we explicitly solicited the most common side effects of memantine (headache, dizziness, confusion, constipation, diarrhea, and fatigue). Attribution was defined as 